Cargando…
Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations
Microfluidic technique has emerged as a promising tool for the production of stable and monodispersed nanoparticles (NPs). In particular, this work focuses on liposome production by microfluidics and on factors involved in determining liposome characteristics. Traditional fabrication techniques for...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348465/ https://www.ncbi.nlm.nih.gov/pubmed/34360832 http://dx.doi.org/10.3390/ijms22158064 |
_version_ | 1783735346543984640 |
---|---|
author | Ballacchino, Giulia Weaver, Edward Mathew, Essyrose Dorati, Rossella Genta, Ida Conti, Bice Lamprou, Dimitrios A. |
author_facet | Ballacchino, Giulia Weaver, Edward Mathew, Essyrose Dorati, Rossella Genta, Ida Conti, Bice Lamprou, Dimitrios A. |
author_sort | Ballacchino, Giulia |
collection | PubMed |
description | Microfluidic technique has emerged as a promising tool for the production of stable and monodispersed nanoparticles (NPs). In particular, this work focuses on liposome production by microfluidics and on factors involved in determining liposome characteristics. Traditional fabrication techniques for microfluidic devices suffer from several disadvantages, such as multistep processing and expensive facilities. Three-dimensional printing (3DP) has been revolutionary for microfluidic device production, boasting facile and low-cost fabrication. In this study, microfluidic devices with innovative micromixing patterns were developed using fused deposition modelling (FDM) and liquid crystal display (LCD) printers. To date, this work is the first to study liposome production using LCD-printed microfluidic devices. The current study deals with 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) liposomes with cholesterol (2:1) prepared using commercial and 3D-printed microfluidic devices. We evaluated the effect of microfluidic parameters, chip manufacturing, material, and channel design on liposomal formulation by analysing the size, PDI, and ζ-potential. Curcumin exhibits potent anticancer activity and it has been reported that curcumin-loaded liposomes formulated by microfluidics show enhanced encapsulation efficiency when compared with other reported systems. In this work, curcumal liposomes were produced using the developed microfluidic devices and particle sizing, ζ-potential, encapsulation efficiency, and in vitro release studies were performed at 37 °C. |
format | Online Article Text |
id | pubmed-8348465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83484652021-08-08 Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations Ballacchino, Giulia Weaver, Edward Mathew, Essyrose Dorati, Rossella Genta, Ida Conti, Bice Lamprou, Dimitrios A. Int J Mol Sci Article Microfluidic technique has emerged as a promising tool for the production of stable and monodispersed nanoparticles (NPs). In particular, this work focuses on liposome production by microfluidics and on factors involved in determining liposome characteristics. Traditional fabrication techniques for microfluidic devices suffer from several disadvantages, such as multistep processing and expensive facilities. Three-dimensional printing (3DP) has been revolutionary for microfluidic device production, boasting facile and low-cost fabrication. In this study, microfluidic devices with innovative micromixing patterns were developed using fused deposition modelling (FDM) and liquid crystal display (LCD) printers. To date, this work is the first to study liposome production using LCD-printed microfluidic devices. The current study deals with 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) liposomes with cholesterol (2:1) prepared using commercial and 3D-printed microfluidic devices. We evaluated the effect of microfluidic parameters, chip manufacturing, material, and channel design on liposomal formulation by analysing the size, PDI, and ζ-potential. Curcumin exhibits potent anticancer activity and it has been reported that curcumin-loaded liposomes formulated by microfluidics show enhanced encapsulation efficiency when compared with other reported systems. In this work, curcumal liposomes were produced using the developed microfluidic devices and particle sizing, ζ-potential, encapsulation efficiency, and in vitro release studies were performed at 37 °C. MDPI 2021-07-28 /pmc/articles/PMC8348465/ /pubmed/34360832 http://dx.doi.org/10.3390/ijms22158064 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ballacchino, Giulia Weaver, Edward Mathew, Essyrose Dorati, Rossella Genta, Ida Conti, Bice Lamprou, Dimitrios A. Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations |
title | Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations |
title_full | Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations |
title_fullStr | Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations |
title_full_unstemmed | Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations |
title_short | Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations |
title_sort | manufacturing of 3d-printed microfluidic devices for the synthesis of drug-loaded liposomal formulations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348465/ https://www.ncbi.nlm.nih.gov/pubmed/34360832 http://dx.doi.org/10.3390/ijms22158064 |
work_keys_str_mv | AT ballacchinogiulia manufacturingof3dprintedmicrofluidicdevicesforthesynthesisofdrugloadedliposomalformulations AT weaveredward manufacturingof3dprintedmicrofluidicdevicesforthesynthesisofdrugloadedliposomalformulations AT mathewessyrose manufacturingof3dprintedmicrofluidicdevicesforthesynthesisofdrugloadedliposomalformulations AT doratirossella manufacturingof3dprintedmicrofluidicdevicesforthesynthesisofdrugloadedliposomalformulations AT gentaida manufacturingof3dprintedmicrofluidicdevicesforthesynthesisofdrugloadedliposomalformulations AT contibice manufacturingof3dprintedmicrofluidicdevicesforthesynthesisofdrugloadedliposomalformulations AT lamproudimitriosa manufacturingof3dprintedmicrofluidicdevicesforthesynthesisofdrugloadedliposomalformulations |